Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirsten A Graeser

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Drug Delivery|June 19, 2009
Applying thermodynamic and kinetic parameters to predict the physical stability of two differently prepared amorphous forms of simvastatinKirsten A Graeser, James E Patterson, Thomas Rades
International Journal of Pharmaceutics|June 27, 2024
Antisense oligonucleotides and their technical suitability to nebulizationLeonardo L Seidl, Regina Moog, Kirsten A Graeser
Pharmaceutics|October 11, 2016
The Role of Configurational Entropy in Amorphous SystemsKirsten A Graeser, James E Patterson, J Axel Zeitler, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 27, 2018
Development of stable liquid formulations for oligonucleotidesJohanna Poecheim, Kirsten A Graeser, Joerg Hoernschemeyer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 28, 2009
Correlating thermodynamic and kinetic parameters with amorphous stabilityKirsten A Graeser, James E Patterson, J Axel Zeitler, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Drug Delivery|June 19, 2009
Applying thermodynamic and kinetic parameters to predict the physical stability of two differently prepared amorphous forms of simvastatinKirsten A Graeser, James E Patterson, Thomas Rades
International Journal of Pharmaceutics|June 27, 2024
Antisense oligonucleotides and their technical suitability to nebulizationLeonardo L Seidl, Regina Moog, Kirsten A Graeser
Pharmaceutics|October 11, 2016
The Role of Configurational Entropy in Amorphous SystemsKirsten A Graeser, James E Patterson, J Axel Zeitler, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 27, 2018
Development of stable liquid formulations for oligonucleotidesJohanna Poecheim, Kirsten A Graeser, Joerg Hoernschemeyer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 28, 2009
Correlating thermodynamic and kinetic parameters with amorphous stabilityKirsten A Graeser, James E Patterson, J Axel Zeitler, et al.
Pageof 1